Celyad SA - Stock Price History | CYAD

Historical daily share price chart and data for Celyad SA since 2021 adjusted for splits. The latest closing stock price for Celyad SA as of October 22, 2021 is 4.98.
  • The all-time high Celyad SA stock closing price was 64.00 on October 05, 2017.
  • The Celyad SA 52-week high stock price is 10.31, which is 107% above the current share price.
  • The Celyad SA 52-week low stock price is 3.76, which is 24.5% below the current share price.
  • The average Celyad SA stock price for the last 52 weeks is 6.39.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Celyad SA Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 9.4770 11.2500 12.4650 4.1800 7.8000 -25.14%
2019 15.6430 19.7600 24.5600 8.4584 10.4200 -42.62%
2018 31.3092 41.4100 47.5200 16.0000 18.1600 -57.87%
2017 38.6413 18.8800 64.0000 18.6300 43.1000 142.68%
2016 32.8531 51.9900 58.6600 16.6982 17.7600 -67.47%
2015 48.0519 54.5700 61.2700 34.0000 54.5899 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.077B $0.000B
Celyad SA is a biopharmaceutical company. The Company develops and commercializes cell based regenerative therapies to treat illnesses where cardiac tissue is lost due to chronic or acute injury. Celyad SA is based in Mont-Saint-Guibert, Belgium.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76